[The proapoptotic factor HLDF in the normal, hyperplastic and neoplastic endometrium]

Area of Science:

• Cell Biology
• Gynecologic Pathology

Context:

• Apoptosis, or programmed cell death, plays a crucial role in normal physiological processes like the menstrual cycle and in pathological conditions such as endometrial disorders.
• Current methods for assessing apoptosis may have limitations in detecting early or late stages.

Purpose:

• To investigate the utility of antibodies to the Human Leukocyte Differentiation Factor (HLDF) as specific markers for apoptosis in endometrial tissues.
• To evaluate the potential of HLDF as an early diagnostic marker for endometrial pathologies.

Summary:

• Antibodies to HLDF specifically identify apoptotic cells, allowing for the quantification of programmed cell death.
• HLDF expression in the cytoplasm enables the detection of apoptosis before morphological signs appear and after apoptotic body formation.
• Increased apoptosis was observed at the end of the normal menstrual cycle and during neoplastic transformation of endometrial cells.

Impact:

• HLDF antibodies can serve as a novel immunohistochemical marker for differentiating benign from malignant endometrial processes.
• This research offers a new tool for assessing apoptosis rates in both normal and pathological endometrial contexts.
• The findings contribute to a better understanding of endometrial cell dynamics and disease progression.